RGLS stock – Knox Daily

Insiders Updates

In a filing, Regulus Therapeutics Inc revealed its Director Collier Kathryn J acquired Company’s shares for reported $7280.0 on Jul

Insiders Updates

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Regulus Therapeutics

Analysts Viewpoint

Regulus Therapeutics Inc’s filing revealed that its Director Collier Kathryn J acquired Company’s shares for reported $7280.0 on Jul 25

Insiders Updates

Regulus Therapeutics Inc’s filing revealed that its Director Collier Kathryn J acquired Company’s shares for reported $7280.0 on Jul 25

Stock Earnings

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

News

Regulus Therapeutics Inc. (RGLS) shares gained 15.69% to $1.92 in Monday’s early session after reporting positive clinical trial results. A

Tag: RGLS stock